Evidence map›Paper›PMID 40587435›Full record

ArticlePloS one2025

EDTA tubes are suitable for insulin and C-peptide measurement in resource-limited settings and can be stored at room temperature for up to 24 hours.

Nathan Mubiru, Rogers Mukasa, Isaac Sekitoleko, Priscilla A Balungi, Ronald M Kakumba, Terry Ongaria, Hubert Nkabura, Moffat Nyirenda, Anxious J Niwaha, Wisdom P Nakanga

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Nathan MubiruClinical Diagnostic Laboratory Medical Research Council/ Uganda Virus Research Institute and LSHTM Uganda Research Unit, Entebbe, Uganda.ORCID 0000-0003-3826-9374
Rogers MukasaClinical Diagnostic Laboratory Medical Research Council/ Uganda Virus Research Institute and LSHTM Uganda Research Unit, Entebbe, Uganda.
Isaac SekitolekoNon-communicable diseases Theme, Medical Research Council/Uganda Virus Research Institute and LSHTM Uganda Research Unit, Entebbe, Uganda.
Priscilla A BalungiClinical Diagnostic Laboratory Medical Research Council/ Uganda Virus Research Institute and LSHTM Uganda Research Unit, Entebbe, Uganda.
Ronald M KakumbaNon-communicable diseases Theme, Medical Research Council/Uganda Virus Research Institute and LSHTM Uganda Research Unit, Entebbe, Uganda.
Terry OngariaNon-communicable diseases Theme, Medical Research Council/Uganda Virus Research Institute and LSHTM Uganda Research Unit, Entebbe, Uganda.
Hubert NkaburaNon-communicable diseases Theme, Medical Research Council/Uganda Virus Research Institute and LSHTM Uganda Research Unit, Entebbe, Uganda.
Moffat NyirendaNon-communicable diseases Theme, Medical Research Council/Uganda Virus Research Institute and LSHTM Uganda Research Unit, Entebbe, Uganda.
Anxious J NiwahaNon-communicable diseases Theme, Medical Research Council/Uganda Virus Research Institute and LSHTM Uganda Research Unit, Entebbe, Uganda.
Wisdom P NakangaNon-communicable diseases Theme, Medical Research Council/Uganda Virus Research Institute and LSHTM Uganda Research Unit, Entebbe, Uganda.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionInsulin and C-peptide assessment are important in characterization and management of diabetes. However, their adoption and increased clinical use in low resource settings (LRSs) is partly hindered by logistical factors including supplies required for pre-analytical sample handling and limited infrastructure. We aimed to determine the effects of altered sample processing conditions on stability of insulin and C-peptide at the pre-analytical stage.

methodsRandom (non-fasted) blood samples were drawn from ten healthy (glucose range 4.1-8.0 mmol/L) participants. We investigated the mean % change from baseline of C-peptide and insulin in serum (plain tubes) vs plasma (K2EDTA tubes), centrifuged vs uncentrifuged, room vs cool box temperature on the stability of C-peptide and insulin up to 24 hours using Wilcoxon signed rank test. Results were considered clinically significant if the percentage change was > 10% and if the p-value was < 0.05.

resultsEight patients were included in the final analysis, while two were excluded due to hemolysis. C-peptide and insulin levels stayed above 90% of the baseline concentration in K2EDTA tubes across all storage and processing conditions for up to 24 hours. In contrast, samples collected in plain serum tubes kept at room temperature and uncentrifuged, C-peptide and insulin levels decreased significantly to 51% (p = 0.006) and 62% (p = 0. 083) respectively, similarly insulin levels for centrifuged samples declined to 64% (p = 0.083). All iced and centrifuged serum samples remained above 90% of baseline concentration.

conclusionsIn resource-limited settings where insulin and C-peptide tests are limited to central laboratories and highly dependent on sample referral systems, these tests can be reliably measured without the need for immediate centrifugation or processing from samples collected in whole blood K2EDTA tubes uncentrifuged kept at room temperature and processed within 24hours.

Indexed as

Blood Specimen CollectionC-PeptideEdetic AcidInsulinAdultFemaleHumansMaleMiddle AgedResource-Limited SettingsTemperatureC-PeptideEdetic AcidInsulin

Identifiers

PMID40587435
PMCPMC12208407

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.